Who owns LENZ Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of LENZ from SEC Form 13F filings across 138 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 138 institutions disclosed 30.6M shares of LENZ Therapeutics, Inc. worth $117.6M — about 97.4% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
138
13F holders
$117.6M
value, 2026 filers
97.4%
of shares outstanding (30.6M sh)
19
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of LENZ's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 4.2M | $16.0M | 0.2% | 13.3% | 0.0% |
| 2 | Alpha Wave Global, LP | 3.6M | $13.9M | 0.3% | 11.5% | 0.0% |
| 3 | BlackRock, Inc. | 3.4M | $13.2M | 0.0% | 10.9% | +50.0% |
| 4 | Versant Venture Management, LLC | 2.7M | $10.2M | 9.4% | 8.5% | 0.0% |
| 5 | MILLENNIUM MANAGEMENT LLC | 1.2M | $4.5M | 0.0% | 3.7% | -23.1% |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | $4.2M | 0.0% | 3.5% | 0.0% |
| 7 | 72 Investment Holdings, LLC | 1.0M | $3.9M | 7.1% | 3.2% | 0.0% |
| 8 | Squarepoint Ops LLC | 966,920 | $3.7M | 0.0% | 3.1% | -44.7% |
| 9 | Blue Owl Capital Holdings LP | 781,722 | $3.0M | 0.5% | 2.5% | +3.3% |
| 10 | TWO SIGMA INVESTMENTS, LP | 714,588 | $2.7M | 0.0% | 2.3% | +150.2% |
| 11 | C WorldWide Group Holding A/S | 700,000 | $2.7M | 0.1% | 2.2% | 0.0% |
| 12 | Trexquant Investment LP | 624,230 | $2.4M | 0.0% | 2% | +25.5% |
| 13 | FMR LLC | 613,374 | $2.4M | 0.0% | 2% | -82.8% |
| 14 | PRIMECAP MANAGEMENT CO/CA/ | 472,200 | $1.8M | 0.0% | 1.5% | 0.0% |
| 15 | TANG CAPITAL MANAGEMENT LLC | 451,114 | $1.7M | 0.1% | 1.4% | 0.0% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 434,515 | $1.7M | 0.0% | 1.4% | -23.0% |
| 17 | STATE STREET CORP | 421,844 | $1.6M | 0.0% | 1.3% | +3.7% |
| 18 | MORGAN STANLEY | 409,348 | $1.6M | 0.0% | 1.3% | -13.5% |
| 19 | Qube Research & Technologies Ltd | 390,391 | $1.5M | 0.0% | 1.2% | -19.0% |
| 20 | GOLDMAN SACHS GROUP INC | 348,914 | $1.3M | 0.0% | 1.1% | +131.6% |
| 21 | ACADIAN ASSET MANAGEMENT LLC | 328,760 | $1.3M | 0.0% | 1% | +1148.3% |
| 22 | Affinity Asset Advisors, LLC | 300,000 | $1.2M | 0.0% | 1% | +200.0% |
| 23 | MARSHALL WACE, LLP | 289,473 | $1.1M | 0.0% | 0.9% | -41.3% |
| 24 | BML Capital Management, LLCNEW | 283,114 | $1.1M | 0.6% | 0.9% | new |
| 25 | Rock Springs Capital Management LP | 257,460 | $988,646 | 0.1% | 0.8% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.